Integra Lifesciences reported $315.83M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbott ABT:US $ 12647M 458M
Abiomed ABMD:US $ 138.46M 11.66M
Becton, Dickinson and BDX:US $ 6657M 78M
Cooper Companies COO:US $ 1664.4M 932.3M
Globus Medical GMED:US $ 141.49M 1.33M
Insulet PODD:US $ 215M 13.8M
Integra Lifesciences IART:US $ 315.83M 24.19M
Orthofix International OFIX:US $ 88.21M 17.62M